Questcor Pharmaceuticals Inc (NASDAQ:QCOR)
| 34.86 Data as of May 24 |  -0.43 / -1.22%Today’s Change | 17.25 Today|||52-Week Range 58.91 | +30.46% Year-to-Date |
Latest QCOR News | Press Releases
| Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Laggard May 21 / TheStreet.com |
Today’s Trading
| Previous close | 35.29 |
| Today’s open | 35.33 |
| Day’s range | 34.02 - 35.42 |
| Volume | 1,373,635 |
| Average volume (3 months) | 1,979,203 |
| Market cap | $2.1B |
| Dividend yield | 2.87% |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +159.50% |
| Earnings growth (this year) | +18.55% |
| Earnings growth (next 5 years) | +20.50% |
| Revenue growth (last year) | +133.44% |
| P/E ratio | 10.8 |
| Price/Sales | 3.16 |
| Price/Book | 12.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MNKDMannkind Corp | -0.30 | -4.38% |
| MDCOThe Medicines Co | -0.33 | -0.99% |
| OPKOPKO Health Inc | -0.04 | -0.57% |
| ARNAArena Pharmaceutical... | +0.24 | +2.99% |
Data as of 4:02pm ET, 05/24/2013
Financials
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.96 |
| Annual revenue (last year) | $509.3M |
| Annual profit (last year) | $197.7M |
| Net profit margin | 38.81% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Don Matthew Bailey, MBA |
Chief Operating Officer Stephen Lahue Cartt, MBA |
Corporate headquarters Anaheim, California |
Forecasts
